The U.S. Food and Drug Administration (FDA) announced on Jan. 13 that Philips is correcting the Monitoring Service Application used with Mobile Cardiac Telemetry Monitoring as some electrocardiogram ...
Personalized heart digital twin models accurately detect substrate and functional abnormalities during ablation for scar-dependent ventricular tachycardia (VT), according to findings from a ...
The SUMMIT trial compared the safety and efficacy of tirzepatide among patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Results from the trial concluded that treatment ...
A novel artificial intelligence (AI) model applied to a 12-lead electrocardiogram (ECG) image was able to identify individuals at elevated risk of heart failure (HF) across multinational cohorts ...
"Wildfires, compound extreme events, climate change and cardiovascular health," are the central theme of an editorial authored by Kai Chen, PhD; Yuan Lu, ScD, and Harlan M. Krumholz, MD, SM, FACC; in ...
A polypill for cardiovascular disease may be cost saving and a high value treatment in a low-income, majority Black population with limited health care access at a price point of $463, according to ...
Overweight and obesity are common in patients with heterozygous familial hypercholesterolemia (HeFH) and are associated with a greater risk of atherosclerotic cardiovascular disease (ASCVD) starting ...
The utility of left atrial appendage occlusion (LAAO) as a therapy for stroke prevention in patients with nonvalvular atrial fibrillation (AFib) is the focus of a State-of-the-Art Review published Jan ...
Check out a new slide lecture, "Cardiac Amyloidosis Foundations," as part of ACC's free online course, Cardiac Amyloidosis: Accelerating Diagnosis and Treatment. Learn to identify symptomology of ...
Whether you are a seasoned attendee or attending your first ACC Annual Scientific Session this year, don't miss the CV Team Section Town Hall, taking place ahead of ACC.25 on Wednesday, March 12 at ...
ACC's CV Team Section is offering travel awards for cardiovascular team members to attend ACC.25, taking place March 29-31, in Chicago, IL. Expenses including airfare, lodging, meals, and ground ...
A new collaboration between JACC and the U.S. Food and Drug Administration (FDA), will give cardiovascular clinicians a voice in shaping priorities for postmarket evidence generation in cardiovascular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback